Clinical findings in 111 cases of influenza A (H7N9) virus infection.

By Hai-Nv Gao, Hong Zhou Lu, B. Cao, B. Du, H. Shang, J. Gan, Shuihua Lu, Yi-da Yang, Qiang Fang, Yinzhong Shen and 32 more. New England Journal of Medicine, 2013

681 citations recorded by the source corpus.

Subfields: Epidemiology, Virology

View Paper: https://www.semanticscholar.org/paper/b88458af97db660eb44832107f58a59432520170

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yanrong Guo
2. Qing Cao
3. Zheng-yi Ni
4. Z. Hong
5. W. Liang
6. Wei-Jie Guan
7. Yu Hu
8. Yuanyang Tan

Citations in the corpus

• The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status (2020, result): “Similar to H7N9 patients [58], the elderly male with comorbidities and ARDS showed a higher death risk.”
• Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis (2020, background): “4-fold increased risk of developing acute respiratory distress syndrome in patients with H7N9 infection [9].”
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (2020, background): “23 For severe mixed infections, in addition to the virulence factors of pathogens, the host's immune status is also one of the important factors.”
• Clinical Characteristics of Coronavirus Disease 2019 in China (2020, positive): “were used in a previous study to assess the severity of other serious infectious diseases, such as H7N9 infection.(16) Secondary end points were the rate of death and the time from symptom onset until the composite end point and until each component of the composite end point.”